These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23994691)

  • 1. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
    Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
    Cavalieri EL; Rogan EG
    Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
    Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
    Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
    Cavalieri EL; Rogan EG; Zahid M
    Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
    Cavalieri EL; Rogan EG
    IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
    Yager JD
    Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.
    Cavalieri EL; Rogan EG
    Clin Transl Med; 2016 Mar; 5(1):12. PubMed ID: 26979321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.
    Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.
    Cavalieri EL; Rogan EG; Chakravarti D
    Cell Mol Life Sci; 2002 Apr; 59(4):665-81. PubMed ID: 12022473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
    Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
    Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
    Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and prevention of prevalent types of cancer.
    Cavalieri EL; Rogan EG
    J Rare Dis Res Treat; 2017; 2(3):22-29. PubMed ID: 30854528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
    Cavalieri EL; Stack DE; Devanesan PD; Todorovic R; Dwivedy I; Higginbotham S; Johansson SL; Patil KD; Gross ML; Gooden JK; Ramanathan R; Cerny RL; Rogan EG
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10937-42. PubMed ID: 9380738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity.
    Saeed M; Zahid M; Gunselman SJ; Rogan E; Cavalieri E
    Steroids; 2005 Jan; 70(1):29-35. PubMed ID: 15610894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
    Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
    Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.
    Chakravarti D; Venugopal D; Mailander PC; Meza JL; Higginbotham S; Cavalieri EL; Rogan EG
    Mutat Res; 2008 Jan; 649(1-2):161-78. PubMed ID: 17931959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
    Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
    Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.